BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6147448)

  • 21. The pathophysiology and management of primary pulmonary hypertension.
    Fein SA; Frishman WH
    Cardiol Clin; 1987 Nov; 5(4):563-76. PubMed ID: 2900068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma].
    Hunzelmann N; Riemekasten G
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S325-7. PubMed ID: 17139598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs for hypertension.
    Med Lett Drugs Ther; 1993 Jun; 35(899):55-60. PubMed ID: 8099706
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of complications associated with systemic sclerosis.
    Moore SC; Desantis ER
    Am J Health Syst Pharm; 2008 Feb; 65(4):315-21. PubMed ID: 18238768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of Raynaud's syndrome].
    Creutzig A
    Dtsch Med Wochenschr; 1993 Oct; 118(41):1487-90. PubMed ID: 8404509
    [No Abstract]   [Full Text] [Related]  

  • 26. [Systemic sclerosis].
    Peltomaa R; Pettersson T; Tuompo R; Luosujärvi R
    Duodecim; 2013; 129(19):1981-91. PubMed ID: 24218729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of Raynaud's phenomenon].
    Boccalon H; Monin A; Reggy M
    Soins Cardiol; 1986 Apr; (38):27-9. PubMed ID: 3637023
    [No Abstract]   [Full Text] [Related]  

  • 28. [Systemic sclerosis].
    Tamborrini G; Distler M; Distler O
    Med Monatsschr Pharm; 2008 May; 31(5):162-70; quiz 171-2. PubMed ID: 18552072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renal involvement in systemic sclerosis].
    Guerini S; Cavazzana I; Venturelli C; Rozzi M; Turina S; Sottini L; Tardanico R; Franceschini F; Scolari F
    G Ital Nefrol; 2007; 24(4):295-310. PubMed ID: 17659501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasodilator therapy for primary pulmonary hypertension.
    Palevsky HI; Fishman AP
    Annu Rev Med; 1985; 36():563-78. PubMed ID: 2859832
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sclerodermic acrosyndromes].
    Carpentier PH
    Rev Prat; 2002 Nov; 52(17):1891-5. PubMed ID: 12532865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischemic finger ulcer as a presenting symptom of systemic sclerosis.
    Balbir-Gurman A; Markovits D; Nahir AM; Rozin A; Braun-Moscovici Y
    Isr Med Assoc J; 2005 Aug; 7(8):531-2. PubMed ID: 16106783
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
    Gore J; Silver R
    Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
    [No Abstract]   [Full Text] [Related]  

  • 34. Vasospasmolytic therapy in patients with SSC.
    Jünger M; Schlez A; Klyscz T; Steins A; Hahn M
    Adv Exp Med Biol; 1999; 455():305-7. PubMed ID: 10599360
    [No Abstract]   [Full Text] [Related]  

  • 35. Vascular disease in systemic sclerosis.
    Poredos P
    Vasa; 2011 Jan; 40(1):3-4. PubMed ID: 21375075
    [No Abstract]   [Full Text] [Related]  

  • 36. [Reflexions on drug therapy of arterial hypertension. Rational therapy].
    Cocco G; Strozzi C; Padula A; Al Yassini K
    Minerva Cardioangiol; 1984 Dec; 32(12):929-40. PubMed ID: 6152333
    [No Abstract]   [Full Text] [Related]  

  • 37. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pulmonary involvement in systemic sclerosis].
    Ioanăş M
    Pneumologia; 2002; 51(3):230-3. PubMed ID: 12602096
    [No Abstract]   [Full Text] [Related]  

  • 39. Daily cyclophosphamide for scleroderma: are patients with the most to gain underrepresented in this trial?
    Wells AU; Latsi P; McCune WJ
    Am J Respir Crit Care Med; 2007 Nov; 176(10):952-3. PubMed ID: 17984310
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination therapies for systemic sclerosis.
    Denton CP; Black CM
    Springer Semin Immunopathol; 2001; 23(1-2):109-29. PubMed ID: 11455851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.